Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
Sassa N, Kato K, Abe S, Iwano S, Ito S, Ikeda M, et al. Evaluation of 11C-choline PET/CT for primary diagnosis and staging of urothelial carcinoma of the upper urinary tract: a pilot study. Eur J Nucl Med Mol Imaging. 2014;41:2232–41.PubMedPubMedCentralCrossRef
2.
Asai S, Fukumoto T, Tanji N, Miura N, Miyagawa M, Nishimura K, et al. Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma. Int J Clin Oncol. 2015;20:1042–7.PubMedCrossRef
3.
Rouprêt M, Nabjuk M, Comperat E, Zigeuner R, Sylvester R, Burger M, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013;63:1059–71.PubMedCrossRef
4.
Fritz GA, Schoellnast H, Deutschmann HA, Quehenberger F, Tillich M. Multiphasic multidetector-row CT (MDCT) in detection and staging of transitional cell carcinomas of the upper urinary tract. Eur Radiol. 2006;16:1244–52.PubMedCrossRef
5.
Maheshwari E, O’Malley ME, Ghai S, Staunton M, Massey C. Split-bolus MDCT urography: upper tract opacification and performance for upper tract tumors in patients with hematuria. AJR Am J Roentgenol. 2010;194:453–8.PubMedCrossRef
6.
Sudakoff GS, Dunn DP, Guralnick ML, Hellman RS, Eastwood D, See WA. Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria. J Urol. 2008;179:862–7.PubMedCrossRef
7.
Millán-Rodríguez F, Palou J, de la Torre-Holguera P, Vayreda-Martija JM, Villavicencio-Mavrich H, Vicente-Rodríguez J. Conventional CT signs in staging transitional cell tumors of the upper urinary tract. Eur Urol. 1999;35:318–22.PubMedCrossRef
8.
Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, et al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol. 2013;189:1662–9.PubMedCrossRef
9.
Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Nakazawa H, Ito F, et al. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol. 2010;17:848–54.PubMedCrossRef
Metadata
Title
Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma
Authors
Fabio Zattoni
Laura Evangelista
Andrea Guttilla
Filiberto Zattoni
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-015-3266-4

Other articles of this Issue 3/2016

European Journal of Nuclear Medicine and Molecular Imaging 3/2016 Go to the issue

Editorial Commentary

68Ga-PSMA-HBED-CC PET/CT: where molecular imaging has an edge over morphological imaging

Original Article

Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study

Original Article

A simple method for determining split renal function from dynamic 99mTc-MAG3 scintigraphic data

Original Article

Different loss of dopamine transporter according to subtype of multiple system atrophy

Editorial

Radiopharmaceuticals in paraganglioma imaging: too many members on board?

Original Article

Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children’s Oncology Group